GSK CEO: Focus on affordable pricing

8:20 AM ET Wed, 26 Oct 2016

GlaxoSmithKline CEO Sir Andrew Witty says rather than being too focused on high drug prices, the company looks to find a price that works, helps affordability, and opens up volume marketplaces. Also Witty weighs in on successor Emma Walmsley.